Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04185935 · ClinicalTrials.gov registry record
Molecular Genetics Studies of Cancer Patients and Their Relatives
A clinical trial of Malignant Neoplasm, sponsored by City of Hope Medical Center.
- Recruiting
- Registry status
- 20
- Study locations
NCT04185935: Recruiting study of Malignant Neoplasm, sponsored by City of Hope Medical Center.
NCT04185935 is a study of Malignant Neoplasm that is actively recruiting participants, run by City of Hope Medical Center. The registry lists this as an open-ended (no fixed target) study. The trial reports 20 study locations across 10 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04185935, a study of Malignant Neoplasm, is actively recruiting participants, sponsored by City of Hope Medical Center.
- RECRUITING
- Registry status
- open-ended (no fixed target)
- Enrollment target
- 20
- Study locations
Study Summary
This trial studies the genetic and behavioral factors that may contribute to the development of specific cancers and how these factors may affect the outcome of the disease in patients with a history of cancer and their relatives.
Conditions Studied
Interventions
- OTHER Questionnaire Administration
- OTHER Biospecimen Collection
Study Locations (20)
California
- John Muir Medical Center-Concord Campus - Concord
- City of Hope Medical Center - Duarte
- Saint Jude Medical Center - Fullerton
- Saddleback Memorial Medical Center - Laguna Hills
- USC / Norris Comprehensive Cancer Center - Los Angeles
- Saint Joseph Hospital - Orange - Orange
- Sutter Cancer Centers Radiation Oncology Services-Roseville - Roseville
- Cancer Center of Santa Barbara - Santa Barbara
Florida
- Lynn Regional Cancer Center - West - Boca Raton
- Holy Cross Hospital - Fort Lauderdale
Illinois
- John H Stroger Jr Hospital of Cook County - Chicago
- Rush University Medical Center - Chicago
Maryland
- Suburban Hospital - Bethesda
- Frederick Oncology Hematology Associates - Frederick
Arizona
- Valleywise Comprehensive Health Center - Phoenix - Phoenix
Idaho
- Kootenai Cancer Center - Post Falls
Iowa
- Mercy Hospital - Cedar Rapids
Massachusetts
- Steward Saint Elizabeth's Medical Center - Brighton
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | open-ended (no fixed target) |
| Start Date | 1997-04-18 |
| Est. Completion | 2033-08-18 |
What NCT04185935 shows while recruiting
NCT04185935 is an observational study that tracks outcomes without assigning an intervention. The registry lists this as an open-ended (no fixed target) study, common for long-running registries that collect data indefinitely.
The record links to 1 condition, with Malignant Neoplasm appearing as the primary indexed condition, and to 2 interventions - of which Questionnaire Administration is the first listed.
NCT04185935 names 20 study sites across 10 states, led by California, Florida, Illinois.
Frequently Asked Questions
What is clinical trial NCT04185935 about?
NCT04185935 is a clinical study titled "Molecular Genetics Studies of Cancer Patients and Their Relatives". This trial studies the genetic and behavioral factors that may contribute to the development of specific cancers and how these factors may affect the outcome of the disease in patients with a history of cancer and their relatives.
What is the current status of trial NCT04185935?
This trial is currently recruiting. The enrollment target is open-ended (no fixed target). The study started on 1997-04-18. Estimated completion is 2033-08-18.
What conditions does trial NCT04185935 study?
This clinical trial studies the following conditions: Malignant Neoplasm.
What interventions are being tested in trial NCT04185935?
The interventions under investigation include: Questionnaire Administration (OTHER), Biospecimen Collection (OTHER).
Who is sponsoring clinical trial NCT04185935?
This trial is sponsored by City of Hope Medical Center, which has 582 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04185935 being conducted?
This trial has 20 study locations across Arizona, California, Florida, Idaho, Illinois. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Malignant Neoplasm
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
A Study of Patritumab Deruxtecan in Pediatric Participants With Relapsed or Refractory Solid Tumors (MK-9999-01C/LIGHTBEAM-U01)
RECRUITING · Phase 1
-
Pre-operative SRS or Post-operative SRS in Treating Cancer Patients With Brain Metastases
RECRUITING · Phase 3
-
Germ-Line Mutations in Blood and Saliva Samples From Patients With Cancer
RECRUITING
-
A Study of OR502, a Monoclonal Antibody Targeting LILRB2, Alone and in Combination With Anticancer Agents
RECRUITING · Phase 1
-
Engagement of American Indians of Southwestern Tribal Nations in Cancer Genome Sequencing
RECRUITING · NA
-
A Study to Evaluate the Safety and Efficacy of MK-3120 in Participants With Advanced Solid Tumors (MK-3120-002)
RECRUITING · Phase 1
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI